Page last updated: 2024-08-21

dexamethasone 21-phosphate and Necrosis

dexamethasone 21-phosphate has been researched along with Necrosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bunya, VY; Dunn, JP; Gritz, DC; Huang, J; Kempen, JH; Maguire, MG; McWilliams, K; O'Neil, EC; Perez, VL; Peskin, E; Suhler, EB; Ying, GS1
Foreman, NK; Liu, AK; Macy, ME1

Other Studies

2 other study(ies) available for dexamethasone 21-phosphate and Necrosis

ArticleYear
Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial.
    The British journal of ophthalmology, 2018, Volume: 102, Issue:8

    Topics: Anterior Eye Segment; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Delivery Systems; Eye Infections; Female; Glucocorticoids; Humans; Iontophoresis; Male; Middle Aged; Necrosis; Randomized Controlled Trials as Topic; Scleritis; Treatment Outcome

2018
Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.
    International journal of radiation oncology, biology, physics, 2009, Nov-15, Volume: 75, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain; Brain Neoplasms; Child; Dexamethasone; Fatal Outcome; Female; Glioma; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Necrosis; Pons; Quality of Life; Radiation Injuries; Radiosurgery; Treatment Outcome; Vascular Endothelial Growth Factor A

2009